GLEN CLOVA SCIENTIFIC LIMITED

Active Glasgow

Research and experimental development on biotechnology

12 employees website.com
Research and experimental development on biotechnology
G

GLEN CLOVA SCIENTIFIC LIMITED

Research and experimental development on biotechnology

Founded 27 Sept 2022 Active Glasgow, Scotland 12 employees website.com
Research and experimental development on biotechnology
Accounts Due 30 Sept 2026 5 months remaining
Confirmation
Net assets £2M £2M 2024 year on year
Total assets £2M £2M 2024 year on year
Total Liabilities £83K £49K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Clyde Offices 2nd Floor 48 West George Street Glasgow G2 1BP Scotland

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for GLEN CLOVA SCIENTIFIC LIMITED (SC745604), an active company based in Glasgow, Scotland. Incorporated 27 Sept 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£2.04M

Increased by £2.04M (+2022915%)

Net Assets

£2.16M

Increased by £2.20M (+6815%)

Total Liabilities

£82.91k

Increased by £49.21k (+146%)

Turnover

N/A

Employees

12

Debt Ratio

4%

Decreased by 2272 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

27 Allotments 5,027,114 Shares £5.44m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Jun 202518,232£21k£1.17
1 Apr 2025201,960£236k£1.17
1 Apr 2025108,748£127k£1.17
1 Apr 2025108,748£127k£1.17
1 Apr 2025201,960£236k£1.17

Officers

Officers

2 active 1 resigned
Status
Galbraith, Daniel Norman, DrDirectorBritishUnited Kingdom603 Apr 2024Active
Lawrence, DavidDirectorBritishScotland638 Apr 2024Active

Shareholders

Shareholders (26)

Norcliffe Nominees Limited
44.5%
2,129,478
John Paul Foerster
12.5%
600,000

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Active
Notified 4 Apr 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

John Paul Foerster

Ceased 4 Apr 2024

Ceased

Steven John Powell

Ceased 4 Apr 2024

Ceased

Dr Steven John Powell

Ceased 4 Apr 2024

Ceased

Group Structure

Group Structure

GLEN CLOVA SCIENTIFIC LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
8 Apr 2026ResolutionResolutions
7 Apr 2026CapitalAllotment of shares (GBP 500.9286) on 2026-04-02
1 Apr 2026OfficersChange to director Mr David Lawrence on 2026-04-01
1 Apr 2026OfficersChange to director Mr Jamie Cruickshank Hodgson on 2026-04-01
1 Apr 2026OfficersChange to director Dr Daniel Norman Galbraith on 2026-04-01
8 Apr 2026 Resolution

Resolutions

7 Apr 2026 Capital

Allotment of shares (GBP 500.9286) on 2026-04-02

1 Apr 2026 Officers

Change to director Mr David Lawrence on 2026-04-01

1 Apr 2026 Officers

Change to director Mr Jamie Cruickshank Hodgson on 2026-04-01

1 Apr 2026 Officers

Change to director Dr Daniel Norman Galbraith on 2026-04-01

Recent Activity

Latest Activity

Resolutions

1 weeks ago on 8 Apr 2026

Allotment of shares (GBP 500.9286) on 2026-04-02

1 weeks ago on 7 Apr 2026

Change to director Mr David Lawrence on 2026-04-01

2 weeks ago on 1 Apr 2026

Change to director Mr Jamie Cruickshank Hodgson on 2026-04-01

2 weeks ago on 1 Apr 2026

Change to director Dr Daniel Norman Galbraith on 2026-04-01

2 weeks ago on 1 Apr 2026